HBB相关血红蛋白病携带状态对无创产前筛查中胎儿分数的影响
一项回顾性查询全基因组测序无创产前筛查实验室数据库的研究,纳入15,853名同时接受HBB和HBA1/HBA2携带者筛查的孕妇,比较校正胎儿分数分布。结果显示HBB携带者校正胎儿分数低于非携带者(p<0.0001),而HBA1/HBA2携带者与非携带者无差异。作者认为HBB致病变异携带者更可能出现较低胎儿分数,若使用胎儿分数阈值可能导致检测失败率升高。
要点
- HBB携带者校正胎儿分数低于非携带者(p<0.0001)。
- HBA1/HBA2携带者与非携带者校正胎儿分数无差异。
- 作者认为HBB携带者胎儿分数降低可能升高基于阈值的检测失败率。
核心结论
- HBB基因致病变异携带者较血红蛋白结构正常女性更可能出现较低胎儿分数,而HBA1/HBA2基因携带者无此现象。
研究设计与样本
- 回顾性查询全基因组测序无创产前筛查实验室数据库,纳入同时接受HBB和HBA1/HBA2携带者筛查的孕妇,排除患这两种疾病者后队列大小为15,853例。
主要发现
- 队列中291例为单纯HBB携带者,1016例为单纯HBA1/HBA2携带者。
- HBB携带者校正胎儿分数低于非携带者(p<0.0001)。
- HBA1/HBA2携带者与非携带者校正胎儿分数无差异。
关键数值与推荐
- 校正胎儿分数通过多变量线性回归获得,校正母亲年龄、孕龄和BMI的系统性影响。
- HBB和HBA1/HBA2携带者的校正胎儿分数分布分别与非携带者用Kolmogorov-Smirnov检验比较。
临床怎么用
- 作者认为HBB致病变异携带者胎儿分数降低,若使用胎儿分数阈值可能导致检测失败率升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated whether there is an association between β-globin (HBB) pathogenic variants and fetal fraction (FF), and whether the association has a clinically relevant impact on non-invasive prenatal screening (NIPS). METHOD: A whole-genome sequencing NIPS laboratory database was retrospectively queried for women who underwent NIPS and carrier screening of both HBB and the α-globin genes (HBA1/HBA2). Women affected with either condition were excluded from the study, yielding a cohort size of 15,853. A "corrected FF" was obtained via multivariable linear regression adjusted for the systematic impacts of maternal age, gestational age and BMI. Corrected FF distributions of HBB and HBA1/HBA2 carriers were each compared to non-carriers using the Kolmogorov-Smirnov test. RESULTS: In this cohort, 291 women were carriers for HBB alone, and 1016 were carriers for HBA1/HBA2 alone. The HBB carriers had a lower corrected FF when compared to non-carriers (p < 0.0001). There was no difference in corrected FF among carriers and non-carriers of HBA1/HBA2. CONCLUSION: Carriers of pathogenic variants in the HBB gene, but not the HBA1/HBA2 genes, are more likely to have lower FF when compared to women with structurally normal hemoglobin. This decrease in FF could result in an elevated test-failure rate if FF thresholds were used.
引用
- Putra M, Kaseniit KE, Hicks MA, et al. The impact of HBB-related hemoglobinopathies carrier status on fetal fraction in noninvasive prenatal screening. Prenat Diagn. 2022. PMID: 35224763. doi:10.1002/pd.6127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。